Connection

Wenjie Tan to Male

This is a "connection" page, showing publications Wenjie Tan has written about Male.
Connection Strength

0.163
  1. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients. Cell Mol Immunol. 2021 08; 18(8):2040-2041.
    View in: PubMed
    Score: 0.013
  2. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 05 12; 323(18):1843-1844.
    View in: PubMed
    Score: 0.012
  3. Comparison of viral and epidemiological profiles of hospitalized children with severe acute respiratory infection in Beijing and Shanghai, China. BMC Infect Dis. 2019 Aug 20; 19(1):729.
    View in: PubMed
    Score: 0.011
  4. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260.
    View in: PubMed
    Score: 0.011
  5. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens. Vaccine. 2018 06 18; 36(26):3740-3746.
    View in: PubMed
    Score: 0.010
  6. Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques. Vaccine. 2017 06 05; 35(25):3347-3353.
    View in: PubMed
    Score: 0.010
  7. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg Microbes Infect. 2016 Nov 09; 5(11):e113.
    View in: PubMed
    Score: 0.009
  8. [Molecular Detection and Genomic Characterization of Enterovirus D68 among Children with Severe Acute Respiratory Infection in Beijing and Shanghai]. Bing Du Xue Bao. 2016 07; 32(4):445-52.
    View in: PubMed
    Score: 0.009
  9. Genetic characterization of human bocavirus among children with severe acute respiratory infection in China. J Infect. 2016 08; 73(2):155-63.
    View in: PubMed
    Score: 0.009
  10. Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge. EBioMedicine. 2015 Oct; 2(10):1438-46.
    View in: PubMed
    Score: 0.009
  11. Prevalence and genetic diversity analysis of human coronavirus OC43 among adult patients with acute respiratory infections in Beijing, 2012. PLoS One. 2014; 9(7):e100781.
    View in: PubMed
    Score: 0.008
  12. First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood. BMC Infect Dis. 2013 Sep 16; 13:433.
    View in: PubMed
    Score: 0.008
  13. A novel human coronavirus: Middle East respiratory syndrome human coronavirus. Sci China Life Sci. 2013 Aug; 56(8):683-7.
    View in: PubMed
    Score: 0.007
  14. Etiology and clinical characterization of respiratory virus infections in adult patients attending an emergency department in Beijing. PLoS One. 2012; 7(2):e32174.
    View in: PubMed
    Score: 0.007
  15. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat Commun. 2021 08 17; 12(1):5000.
    View in: PubMed
    Score: 0.003
  16. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe. 2021 03 10; 29(3):489-502.e8.
    View in: PubMed
    Score: 0.003
  17. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
    View in: PubMed
    Score: 0.003
  18. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
    View in: PubMed
    Score: 0.003
  19. SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial. Int J Infect Dis. 2020 Oct; 99:84-91.
    View in: PubMed
    Score: 0.003
  20. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.003
  21. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
    View in: PubMed
    Score: 0.003
  22. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020 05 29; 368(6494):1016-1020.
    View in: PubMed
    Score: 0.003
  23. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
    View in: PubMed
    Score: 0.003
  24. [Consecutive five-year follow-up analysis of specific IgG antibody of 22 cases of SARS patients after recovery]. Bing Du Xue Bao. 2010 Jul; 26(4):295-7.
    View in: PubMed
    Score: 0.002
  25. [Characterization of human coronavirus 229E infection among patients with respiratory symptom in Beijing, Oct-Dec, 2007]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Oct; 23(5):367-70.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.